Gastroenterology
Advertisement
A new study found that the disease burden of patients with ulcerative colitis is high.
The success of FMT of UC is linked with specific microbiota families.
A study uncovered several potential biomarkers of UC, which may help better describe the disease's underlying mechanisms.
Patients with inflammatory bowel disease have a significantly higher risk of developing atrial fibrillation.
Researchers developed a machine learning model that can distinguish between CD and ITB, which share many clinical features.
A recent study analyzed the association between race/ethnicity and insurance status with outcomes in patients with UC.
A recent study showed no significant causal relationship between 7 lipid factors and the risk of developing IBD.
New research may explain recurrent Crohn disease in children, and it may open the door for novel treatments.
Larry Kosinski, MD, of SonarMD, discusses drivers of medical costs in people living with IBD.
Bowel urgency affects more than a quarter of patients with ulcerative colitis and almost 10% of UC patients in remission.
Patients with refractory UC who are treated with JAKi and withdrawal from therapy have high rates of relapse.
A third of Black and Hispanic patients with inflammatory bowel disease have post-traumatic stress.
"Top-down" treatment is superior to "accelerated step-up" therapy in newly diagnosed Crohn disease.
AI Platforms Give Inaccurate Information on Crohn Disease, Ulcerative Colitis, and Colorectal Cancer
ChatGPT and Google's Bard are not yet a viable source of health-related information for Crohn disease, ulcerative colitis.
Researchers uncovered a potential molecular marker of Crohn disease in adipose-derived stem cells.
Fecal microbial transplantation followed by the right diet is as an effective treatment of ulcerative colitis.
Researchers have identified important pathophysiological mechanisms of a common complication of Crohn disease.
A study assessed the efficacy of a treatment combination in the second-line treatment of metastatic colorectal cancer.
The combination of pembrolizumab and lenvatinib did not improve survival in metastatic CRC.
A systematic review reported that immune checkpoint inhibitor therapy shows promising results in metastatic CRC.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.